Compugen, Bayer in cancer immunotherapy deal

Compugen Ltd. (NASDAQ:CGEN) jumped $2.43 (45%) to $7.89 on Monday after announcing a deal with Bayer AG (Xetra:BAYN) to research and develop antibody-based cancer immunotherapies against two undisclos...